Evidence mapPaperPMID 41874653Full record

Observational studyCalcified tissue international2026

Natural Course of Neuropsychological Functions in Chronic Non-Surgical Hypoparathyroidism on Conventional Therapy: 12 Years of Follow-Up.

Preeti Namjoshi, Snehaa Seetharaman, Soma Saha, Mani Kalaivani, Manjari Tripathi, Devasenathipathy Kandasamy, Sameer Aggarwal, Rajesh Sagar, Ravinder Goswami

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Calcified tissue international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Preeti NamjoshiDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Snehaa SeetharamanDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
Soma SahaDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India.
Mani KalaivaniDepartment of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
Manjari TripathiDepartment of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Devasenathipathy KandasamyDepartment of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India.
Sameer AggarwalDr Sameer Aggarwal's Endocrine Centre, Rohtak, Haryana, India.
Rajesh SagarDepartment of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
Ravinder GoswamiDepartment of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India. gosravinder@aiims.edu.ORCID http://orcid.org/0000-0002-3097-5074

Funding

Department of Health Research, Indian council of medical Sciences, India (IN) R.11012/22/2023-GIA/HR
6 · The paper itself

Abstract

purposeNeuropsychological manifestations are common in chronic hypoparathyroidism (cHypoPT). Here, we report the change in cognitive and neuropsychiatric functions in cHypoPT during long-term follow-up.

designObservational-cohort study.

methodsFifty-four patients with non-surgical idiopathic cHypoPT (M: F = 24:30, age = 47.8 ± 14.0 years, duration of hypoparathyroidism = 24.5 ± 7.7 years), who were evaluated for cognitive, neuropsychiatric function, and quality of life in 2011-12, were re-evaluated in 2023-24 using the same battery of tests. Change in intracranial calcification was compared with previous computed tomography scans. Multivariable regression was used to assess association of change in cognitive and neuropsychiatric function with sex, age, body mass index (BMI), sites of intracranial calcification, and time weighted estimated glomerular filtration rate (eGFR), serum total calcium, phosphate, their product, and ratio.

resultsThe mean global cognitive dysfunction score increased during follow-up (4.04 ± 2.56 to 5.69 ± 2.10, p < 0.001). Motor speed and fine control, memory, trail-making test, Bender-Gestalt test, and quality of life showed significant deterioration. Deterioration in cognition was associated with increased age (p < 0.001). Neuropsychiatric assessment showed significant improvement in somatic concerns, anxiety, tension, and hostility. Male patient, increasing age, and higher BMI showed significant association with improvement in neuropsychiatric function. However, duration of illness and lower eGFR were associated with neuropsychiatric deterioration (p = 0.003 and 0.035). Changes in intracranial-calcification and biochemical control showed no significant association with cognitive and neuropsychiatric functions.

conclusionsHypoparathyroid patients showed a significant decline in cognitive function during follow-up. However, neuropsychiatric function improved during follow-up, more so in males, in older individuals and in those with a higher BMI. Deteriorating cognition could affect the earning and compliance with treatment. Further studies assessing the role of behavioral/drug therapy would be helpful in cHypoPT.

Indexed as

HypoparathyroidismAdultChronic DiseaseCognitionCohort StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedNeuropsychological TestsQuality of LifeChronic hypoparathyroidismIntracranial calcificationLong-term outcomeNeuropsychiatric and cognitive function

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.